What Arlington Scientific does

Arlington Scientific, Inc. (ASI) is a privately held US medical device and in-vitro diagnostics manufacturer founded in 1986 and headquartered in Springville, Utah. The company develops, manufactures, and distributes serological diagnostic test kits and automated analyzers, with its flagship ASI Evolution SR being the world's first and only fully-automated nontreponemal RPR syphilis analyzer — FDA cleared for diagnostic, blood donor screening, and (in 2025) cadaveric donor screening. ASI manufactures over 30 million RPR tests per year and serves more than 1,200 laboratories worldwide, with its primary customers being diagnostic laboratories, blood donor screening facilities, and tissue banks. Beyond RPR, the portfolio includes manual serology kits (VDRL, TPHA, Rubella, and others), the SeraQuest ELISA line (acquired in February 2026 from Awareness Technology, covering CMV, EBV, HSV, Measles, Mumps, Rubella, Syphilis IgG, Toxoplasma, VZV), the non-mammalian blocking buffer lines (Aquatic Block, Balance Blocker, Aqua Block, acquired in 2021), the Rhino-Pro nasal curette, microtiter plates, and medical donor lounges.

The technology stack centers on proprietary automated algorithm-based interpretation of RPR agglutination patterns, an RFID-enabled ASI Smart Rack loading system, mercury-free reagents, and CDC-licensed VDRL synthetic formulation. ASI operates an FDA-registered establishment (#1641328), holds ISO 13485:2016 certification, and several products are CE marked, indicating an FDA- and quality-system-centric manufacturing footprint rather than a software/AI-centric one.

ASI earns revenue primarily through one-time sales of test kits and reagents, hardware sales of the ASI Evolution SR analyzer and accessories, OEM/private label manufacturing, and ancillary sales of medical devices and donor lounge furniture. The company employs a sales-led, quote-based go-to-market motion targeting diagnostic laboratories, blood banks, and tissue banks, executed through direct sales, free evaluation kits, virtual demonstrations, and trade show participation (APHL, ADLM). Pricing is not publicly disclosed and is negotiated via a quote request system. The company is founder/management-owned with no disclosed outside equity investors and has financed two product-line acquisitions (2021 blocking buffers, 2026 SeraQuest ELISA line) through what appears to be organic cash generation rather than external funding rounds.

Name

Arlington Scientific

Legal name

Arlington Scientific, Inc.

Website

https://arlingtonscientific.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

Arlington Scientific is a privately held US diagnostics manufacturer founded in 1986 that develops automated and manual nontreponemal RPR syphilis test kits, serology, and ELISA testing products for diagnostic laboratories, blood donor screening facilities, and tissue banks worldwide.

Ownership category

akta.pro rank

Product category

In-vitro Diagnostics Manufacturing

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Diagnostic test kits
• Syphilis screening
• Serological reagents
• Automated immunoassay
• In-vitro diagnostics manufacturing

Headquarters

HQ city

Springville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Test Kits and Reagents: ASI generates revenue through the sale of manual and automated RPR syphilis test kits, serological test kits (VDRL, TPHA, Rubella, etc.), ELISA test kits, and control sets. Products are sold in various kit sizes with one-time purchase model.
2. Automated Diagnostic Analyzers: Sale of the ASI Evolution SR automated syphilis analyzer and related equipment including the Smart Rack system for laboratory automation.
3. Non-mammalian Blocking Buffers: Sale of research and manufacturing blocking buffer products including Aquatic Block, Balance Blocker, and Aqua Block product lines for IVD manufacturers and R&D institutions.
4. Medical Devices and Equipment: Sale of medical devices including Rhino-Pro curettes for nasal specimen collection and donor lounges for apheresis and blood donor collection.
5. OEM Private Label Manufacturing: ASI offers OEM private label manufacturing services and can customize kits and controls to meet customer needs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Arlington Scientific develops, manufactures, and distributes FDA-cleared in-vitro diagnostic test kits, serological reagents, and automated analyzers. Its flagship offering is the ASI Evolution SR, the world's first fully-automated nontreponemal RPR syphilis analyzer, supported by manual and automated RPR test kits, a serology portfolio (VDRL, TPHA, Rubella, and others), ELISA kits under the SeraQuest brand, non-mammalian blocking buffers, and the Rhino-Pro nasal curette.

Product overview

Arlington Scientific is a medical technology company offering a diversified portfolio of in-vitro diagnostics and laboratory products. The core offering centers on the ASI Evolution SR, the world's first and only fully-automated nontreponemal RPR syphilis analyzer (FDA cleared for diagnostic, blood donor screening, and cadaveric tissue screening), supplemented by the ASI Smart Rack accessory. The company manufactures Manual and Automated RPR Test Kits, a broad Serology Test Kit portfolio (VDRL, TPHA, Rubella, and others), and expanded into ELISA/EIA testing through the acquired SeraQuest brand (CMV, EBV, HSV, Measles, Mumps, Rubella, Syphilis IgG, Toxoplasma, VZV tests). Non-mammalian Blocking Buffers (Aquatic Block, Balance Blocker, Aqua Block product lines) serve research and IVD manufacturing markets. Additional products include the Rhino-Pro nasal curette for viral sample collection and medical donor lounges. The portfolio operates as a platform of diagnostic instruments, reagent kits, and laboratory supplies serving clinical laboratories, blood donor screening facilities, and research institutions.

Differentiator

Problem solved

Functional benefit

Brands

• ASI Evolution® SR: World's first and only fully-automated RPR Syphilis Analyzer, FDA cleared for diagnostic, blood donor screening and cadaveric donor screening.
• ASI Smart Rack™
• Rhino-Pro®
• Aquatic Block™
• Balance Blocker™
• Aqua Block™
• SeraQuest™

Products and services

• ASI Evolution SR Automated RPR Syphilis Analyzer The world's first and only fully-automated nontreponemal RPR syphilis analyzer, FDA cleared for diagnostic, blood donor screening, and cadaveric (non-heart beating) tissue screening. Targets high-throughput clinical laboratories and blood banks.
• Manual RPR Test Kit Nontreponemal Rapid Plasma Reagin manual test for syphilis screening, available in multiple kit sizes, used by clinical diagnostic laboratories.
• Automated RPR Test Kit Nontreponemal Rapid Plasma Reagin test kit designed for automated syphilis screening on the ASI Evolution SR analyzer.
• Serology Test Kits Portfolio Portfolio of serology test kits including VDRL, VDRL Synthetic, TPHA, Rubella, Color Mono, Staph, Color Staph, SLE, RF, Sickle Cell, ASO, CRP, and RPR Control Sets for diagnostic applications.
• SeraQuest ELISA Test Kits Unified ELISA platform acquired from Awareness Technology, covering infectious disease tests for CMV IgG/IgM, EBV, HSV 1/2, Measles, Mumps, Rubella, Syphilis IgG, Toxoplasma, and VZV IgG.
• Non-Mammalian Blocking Buffers (Aquatic Block, Balance Blocker, Aqua Block) Non-mammalian protein blocking buffers for ELISA, EIA, Western Blot, chemiluminescence, and lateral flow assays, offered in PBS and Tris formats as Aquatic Block, Balance Blocker, and Aqua Block lines for IVD manufacturers and research institutions.
• Rhino-Pro Curette Sterile, disposable nasal mucosal collection device used to collect specimens with up to 1,000 times more cells than other methods; designed for rapid viral testing including RSV sample collection. CE marked and made in the USA.
• ASI Medical Donor Lounges Premium medical donor lounges designed for apheresis and blood donor collection, supplied to blood centers and donor facilities.
• Aquatic Block Blocking Buffer (PBS format, catalog PP81P) PBS-formatted non-mammalian blocking buffer for ELISA, EIA, and Western Blot applications; preserved with 0.09% Sodium Azide.
• Aquatic Block Blocking Buffer (Tris format, catalog PP81T) Tris-formatted non-mammalian blocking buffer for ELISA, EIA, and Western Blot applications; preserved with 0.09% Sodium Azide.
• Balance Blocker Universal Blocking Reagent (PBS format, catalog PP91P) PBS-formatted universal non-mammalian blocking reagent for EIA, ELISA, Western Blot, and lateral flow applications.
• Balance Blocker Universal Blocking Reagent (Tris format, catalog PP91T) Tris-formatted universal non-mammalian blocking reagent for EIA, ELISA, Western Blot, and lateral flow applications.
• Aqua Block Blocking Buffer (PBS format, catalog PP82P) PBS-formatted non-mammalian blocking buffer optimized for chemiluminescence, EIA, ELISA, and Western Blot applications.
• Aqua Block Blocking Buffer (Tris format, catalog PP82T) Tris-formatted non-mammalian blocking buffer for chemiluminescence, EIA, ELISA, and Western Blot applications.

Quantifiable outcome

• 90-95% reduction in hands-on time with ASI Evolution SR compared to manual RPR testing
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Awareness Technology, Inc.coreStrategic or Co-development Partner · 12 February 2026Arlington Scientific acquired the EIA/ELISA product line from Awareness Technology, Inc. (Quest International brand). This acquisition expanded ASI's leadership in infectious disease diagnostics, reintroduced as SeraQuest, their unified platform for EIA/ELISA testing.
• Clark McDermith (EastCoast Bio)coreStrategic or Co-development Partner · 11 October 2021Arlington Scientific acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of EastCoast Bio. ASI became the exclusive worldwide manufacturer of these proprietary blocking buffers for IVD manufacturers and R&D institutions.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Bio-Rad Laboratories: Major manufacturer of clinical diagnostics including syphilis serology (RPR/VDRL) test kits and automated immunoassay platforms. Bio-Rad is the most direct competitor in the manual RPR syphilis screening market that ASI has historically dominated.
• Trinity Biotech: Specialty diagnostics company focused on infectious disease serology, including syphilis screening kits (RPR, TPHA) and hemoglobin A1c testing. Trinity Biotech directly competes with ASI in the syphilis serology reagent market.
• Fujirebio (H.U. Group Holdings): Specialty in vitro diagnostics company with deep presence in infectious disease serology including syphilis (TPHA, RPR) and TORCH ELISA assays, directly overlapping ASI's RPR and newly-acquired SeraQuest ELISA portfolios.
• Omega Diagnostics: UK-based specialty diagnostics company producing syphilis (RPR), HIV, and other infectious disease test kits. Comparable in size, niche focus, and product overlap with ASI's serology kit portfolio.

Broad incumbents

• Roche Diagnostics: Global diagnostics leader offering the cobas automated immunoassay platform with broad infectious disease menus including syphilis screening. Represents a large incumbent threat to ASI's automated serology positioning.
• Abbott Diagnostics: Major diagnostics manufacturer with the ARCHITECT immunoassay platform offering syphilis and infectious disease serology at scale. A broad incumbent that competes for the same blood bank and clinical lab customers as ASI.
• Siemens Healthineers: Operates the Atellica and ADVIA Centaur immunoassay systems covering infectious disease and syphilis serology. A broad incumbent competing for high-volume lab automation contracts in ASI's target customer segments.
• Beckman Coulter (Danaher): Major clinical diagnostics manufacturer providing automated immunoassay analyzers and reagents for clinical laboratories including infectious disease serology panels. Competes broadly with ASI in clinical lab channels.

Emerging players

• Surmodics: Provider of proprietary surface coatings and in vitro diagnostic components including blocking buffers and assay reagents to IVD manufacturers. Directly comparable to ASI's non-mammalian blocking buffer product lines serving IVD OEMs.
• Hologic: Diagnostics company with presence in women's health and infectious disease testing, including molecular STI assays that represent an emerging alternative to traditional RPR-based syphilis screening workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/arlingtonscientific
• LinkedInlinkedin.com/company/arlington-scientific-inc-

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arlington Scientific